F
Fennec Pharmaceuticals Inc
SWB:RV41
Fennec Pharmaceuticals Inc
SWB:RV41
Price:
5.9
EUR
Market Closed
Market Cap:
€94.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
F
|
Fennec Pharmaceuticals Inc
SWB:RV41
|
US |
|
W
|
Wacker Neuson SE
XMUN:WAC
|
DE |
|
F
|
Fresnillo PLC
DUS:FNL
|
MX |
|
A
|
Amgen Inc
XBER:AMG
|
US |
|
G
|
Goldwind Science & Technology Co Ltd
XMUN:CXGH
|
CN |
|
S
|
Schroders PLC
F:PYX
|
UK |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
XHAM:BOY
|
ES |
|
OMV AG
OTC:OMVKY
|
AT |
|
Nucor Corp
NYSE:NUE
|
US |
|
G
|
Grifols SA
MAD:GRF.P
|
ES |
|
Alkemy SpA
MIL:ALK
|
IT |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc
Wall Street analysts forecast RV41 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RV41 is 13.17 EUR with a low forecast of 11.18 EUR and a high forecast of 16.1 EUR.
Lowest Forecast
Price Target
11.18
EUR
90% Upside
Average Forecast
Price Target
13.17
EUR
123% Upside
Highest Forecast
Price Target
16.1
EUR
173% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
13.17
EUR
13.17
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 13.17 EUR with a low forecast of 11.18 EUR and a high forecast of 16.1 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
22%
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
